Vaccination reduces simian-human immunodeficiency virus sequence reversion through enhanced viral control

J Virol. 2010 Dec;84(24):12782-9. doi: 10.1128/JVI.01193-10. Epub 2010 Sep 29.

Abstract

It has been suggested that vaccination prior to infection may direct the mutational evolution of human immunodeficiency virus type 1 (HIV-1) to a less fit virus, resulting in an attenuated course of disease. The present study was initiated to explore whether prior immunization might prevent the reversion of the virus to the wild-type form. Mamu-A*01 monkeys were vaccinated to generate a cytotoxic T-lymphocyte response to the immunodominant Gag p11C epitope and were then challenged with a cloned pathogenic CXCR4-tropic simian-human immunodeficiency virus (SHIV) expressing a mutant Gag p11C sequence (Δp11C SHIV). The epitopic and extraepitopic compensatory mutations introduced into gag of Δp11C SHIV resulted in attenuated replicative capacity and eventual reversions to the wild-type Gag p11C sequence in naïve rhesus monkeys. However, in vaccinated rhesus monkeys, no reversions of the challenge virus were observed, an effect that may have been a consequence of significantly decreased viral replication rather than a redirection of the mutational evolution of the virus. These findings highlight the multifactorial pressures that affect the evolution of primate immunodeficiency viruses.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • CD8-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / virology
  • Epitopes, T-Lymphocyte / immunology
  • Flow Cytometry
  • Gene Products, gag / genetics
  • Histocompatibility Antigens Class I / immunology
  • Humans
  • Macaca mulatta
  • Molecular Sequence Data
  • Point Mutation
  • RNA, Messenger / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • SAIDS Vaccines / therapeutic use*
  • Sequence Homology, Amino Acid
  • Simian Acquired Immunodeficiency Syndrome / genetics
  • Simian Acquired Immunodeficiency Syndrome / immunology*
  • Simian Acquired Immunodeficiency Syndrome / prevention & control*
  • Simian Immunodeficiency Virus / genetics
  • Simian Immunodeficiency Virus / physiology*
  • T-Lymphocytes, Cytotoxic / immunology
  • T-Lymphocytes, Cytotoxic / virology
  • Vaccination
  • Viral Load
  • Virus Replication / genetics*

Substances

  • Epitopes, T-Lymphocyte
  • Gene Products, gag
  • Histocompatibility Antigens Class I
  • Mamu-A 01 antigen
  • RNA, Messenger
  • SAIDS Vaccines